Jovanche Vitanovski/123rf.comCancerOne Bioscience raises €15m to leverage AI tumour profilingParis-based One Biosciences, a pioneering “techbio” company at the intersection of artificial intelligence and oncology, has announced a €15 million Series A funding round to accelerate the clinical … more ➔
Vedran Vukoja AKA vepar5, stock.adobe.comUnited KingdomBold UK-Strategy in Life SciencesThe UK Government launched a ten-year Life Sciences Sector Plan to drive innovation and health reform within the NHS. This Life Sciences Sector Plan is part of its broader Industrial Strategy. more ➔
Axxam S.p.APreclinical target validationClinical data meet preclinical validation: Axxam´s partnership with Molecular HealthThat deserves a closer look: The recently announced partnership between Axxam S.p.A., a leading provider of integrated early discovery services, and Molecular Health GmbH, a pioneer in AI-powered data … more ➔
Oncomatryx Biopharma S.L.Antibody-Drug-ConjugateOncomatryx Secures EU Funding to Advance Antibody-Drug Conjugate PlatformSpanish biotechnology company Oncomatryx Biopharma has been selected for funding under the European Innovation Council (EIC) Accelerator, part of the EU’s Horizon Europe 2021–2027 Research and Innovation … more ➔
David_SMC from PixabayAcquisitionVerona Pharma: A Transatlantic Success Story in the Biotech LandscapeThe planned US$10 billion acquisition of UK-based Verona Pharma by US pharmaceutical giant Merck & Co. underscores several key dynamics reshaping the global biotech industry. Not only does the deal reflect … more ➔
AmphiStar BVBio-basedAmphiStar: €12.5m EIC Funding to Advance Commercialisation of Bio-Based SurfactantsThe new funding includes €2.5m grant and €10m equity investment and supports Belgian AmphiStar’s potential to reshape the surfactants market. This investment will accelerate scale-up and market … more ➔
Cyril MarcilhacyCellular AgricultureUK Food Standards Agency accepts Gourmey’s application for cultivated Foie GrasThe British Food Standards Agency (FSA) has formally accepted an application by French start-up Gourmey SAS for regulatory approval of its cultivated foie gras, a product developed using cellular agriculture … more ➔
Rheticus/EvonikCarbon captureFirst step towards scaling chemical production from CO₂As part of the green transformation of North Rhine-Westphalia’s former coal-mining region, independent assessors have recommended the co-financing of two biotechnology processes developed at pilot … more ➔
Nuclidium AGRadiopharmaceuticalsNuclidium fuels next radiopharma waveBasel-based NUCLIDIUM AG has successfully closed a Series B financing round of CHF 79 million (EUR 84 million) to advance the development of its copper-based radiopharmaceutical platform. The round was … more ➔
Actithera Norway ASRadiopharmaceuticalsActithera: Radiopharma Funding Gathers Huge MomentumThe biotech company Actithera, with locations in Cambridge, USA, and Oslo, Norway, has successfully closed a major Series A round, raising US $75.5 million. Its isotope-agnostic platform — designed … more ➔
Jovanche Vitanovski/123rf.com
Vedran Vukoja AKA vepar5, stock.adobe.com
Axxam S.p.A
Oncomatryx Biopharma S.L.
David_SMC from Pixabay
AmphiStar BV
Cyril Marcilhacy
Rheticus/Evonik
Nuclidium AG
Actithera Norway AS